These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8849331)

  • 21. Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis.
    Wharton W; Leof E; Pledger WJ; O'Keefe EJ
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5567-71. PubMed ID: 6291052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basic and acidic fibroblast growth factors modulate the epidermal growth factor receptor by a protein kinase C-independent pathway.
    Hicks K; Friedman B; Rosner MR
    Biochem Biophys Res Commun; 1989 Oct; 164(2):796-803. PubMed ID: 2818588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity.
    Buchdunger E; Trinks U; Mett H; Regenass U; Müller M; Meyer T; McGlynn E; Pinna LA; Traxler P; Lydon NB
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2334-8. PubMed ID: 8134396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
    Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
    J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro.
    Rossi MJ; Chegini N; Masterson BJ
    Endocrinology; 1992 Mar; 130(3):1716-27. PubMed ID: 1311246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative analysis of the photosensitized inhibition of growth-factor regulated protein kinases by hypericin-derivatives.
    Agostinis P; Donella-Deana A; Cuveele J; Vandenbogaerde A; Sarno S; Merlevede W; de Witte P
    Biochem Biophys Res Commun; 1996 Mar; 220(3):613-7. PubMed ID: 8607812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
    Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Regenass U; Lydon NB
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2558-62. PubMed ID: 7708684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes.
    Aasrum M; Ødegård J; Sandnes D; Christoffersen T
    Biochim Biophys Acta; 2013 Dec; 1833(12):3286-3294. PubMed ID: 24126105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
    Wang Z; Wang M; Carr BI
    J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin.
    Korutla L; Cheung JY; Mendelsohn J; Kumar R
    Carcinogenesis; 1995 Aug; 16(8):1741-5. PubMed ID: 7634398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
    J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.
    Moriai T; Kobrin MS; Hope C; Speck L; Korc M
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10217-21. PubMed ID: 7937865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photosensitized inhibition of growth factor-regulated protein kinases by hypericin.
    Agostinis P; Vandenbogaerde A; Donella-Deana A; Pinna LA; Lee KT; Goris J; Merlevede W; Vandenheede JR; De Witte P
    Biochem Pharmacol; 1995 May; 49(11):1615-22. PubMed ID: 7786302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mechanism for isoprenaline-stimulated proliferation of rat parotid acinar cells involving the epidermal growth factor receptor and cell surface galactosyltransferase.
    Purushotham KR; Dunn WA; Schneyer CA; Humphreys-Beher MG
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):767-76. PubMed ID: 1622394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-derived growth factor mimics phorbol diester action on epidermal growth factor receptor phosphorylation at threonine-654.
    Davis RJ; Czech MP
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4080-4. PubMed ID: 2987962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor stimulates the anchorage-independent growth of human squamous cell carcinomas overexpressing its receptors.
    Lee K; Tanaka M; Shigeno C; Yamamoto I; Ohta S; Rikimaru K; Hatanaka M; Konishi J
    Biochem Biophys Res Commun; 1990 May; 168(3):905-11. PubMed ID: 2346491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
    Vacca F; Bagnato A; Catt KJ; Tecce R
    Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement.
    Chen P; Xie H; Sekar MC; Gupta K; Wells A
    J Cell Biol; 1994 Nov; 127(3):847-57. PubMed ID: 7962064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gambogic acid induces G0/G1 cell cycle arrest and cell migration inhibition via suppressing PDGF receptor β tyrosine phosphorylation and Rac1 activity in rat aortic smooth muscle cells.
    Liu Y; Li W; Ye C; Lin Y; Cheang TY; Wang M; Zhang H; Wang S; Zhang L; Wang S
    J Atheroscler Thromb; 2010 Sep; 17(9):901-13. PubMed ID: 20543524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.